This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Sep;36(7):362-4.

doi: 10.1097/CJI.0b013e31829fb7c8.

Cracking the stone: combination vaccination and CTLA-4 blockade in pancreatic cancer

David L Bajor¹, Robert H Vonderheide

Affiliations

PMID: 23924787
DOI: 10.1097/CJI.0b013e31829fb7c8

Comment

Cracking the stone: combination vaccination and CTLA-4 blockade in pancreatic cancer

David L Bajor et al. J Immunother. 2013 Sep.

. 2013 Sep;36(7):362-4.

doi: 10.1097/CJI.0b013e31829fb7c8.

Authors

David L Bajor¹, Robert H Vonderheide

Affiliation

¹ Department of Medicine, Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

PMID: 23924787
DOI: 10.1097/CJI.0b013e31829fb7c8

No abstract available

PubMed Disclaimer

Comment on

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.
Le DT, Lutz E, Uram JN, Sugar EA, Onners B, Solt S, Zheng L, Diaz LA Jr, Donehower RC, Jaffee EM, Laheru DA. Le DT, et al. J Immunother. 2013 Sep;36(7):382-9. doi: 10.1097/CJI.0b013e31829fb7a2. J Immunother. 2013. PMID: 23924790 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information